Particularly, PD-1high Tregs and PD-1+ CD8+ resident memory T cells were more prominent in HBV-related HCC, suggesting that PD-1 blockade might be a suited strategy for this etiology. This evidence concerns the gene CD8A and hepatocellular carcinoma.